A Study of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is a phase II, randomised, double-blind, placebo-controlled, multicenter study to assess
the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE)
participants.